WO2025036307 - APPLICATION OF ANTI-FRα ANTIBODY-DRUG CONJUGATE IN TREATMENT OF DISEASES
National phase entry is expected:
Publication Number
WO/2025/036307
Publication Date
20.02.2025
International Application No.
PCT/CN2024/111203
International Filing Date
09.08.2024
Title **
[English]
APPLICATION OF ANTI-FRα ANTIBODY-DRUG CONJUGATE IN TREATMENT OF DISEASES
[French]
APPLICATION D'UN CONJUGUÉ ANTICORPS-MÉDICAMENT ANTI-FRα DANS LE TRAITEMENT DE MALADIES
[Chinese]
抗FRΑ抗体药物偶联物在治疗疾病中的应用
Applicants **
BIO-THERA SOLUTIONS, LTD.
Inventors
FU, Ziyi
SONG, Shuqiang
TANG, Weijia
LI, Shengfeng
YU, Jin-Chen
Priority Data
202311018230.6
11.08.2023
CN
202410347310.4
25.03.2024
CN
202410686915.6
29.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3868 | |
| EPO | Filing, Examination, Granting | 40453 | |
| Japan | Filing, Examination, Granting | 3417 | |
| South Korea | Filing, Examination, Granting | 4927 | |
| USA | Filing, Examination, Granting | 14790 |
Total:
67,455
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
An application of an anti-FRα antibody-drug conjugate in the treatment of diseases. A treatment method comprises: administering an effective amount of the anti-FRα antibody-drug conjugate to a patient in need thereof.[French]
L'invention concerne une application d'un conjugué anticorps-médicament anti-FRα dans le traitement de maladies. Une méthode de traitement comprend : l'administration d'une quantité efficace du conjugué anticorps-médicament anti-FRα à un patient en ayant besoin.[Chinese]
抗FRα抗体药物偶联物在治疗疾病中的应用，治疗方法包括向有需要的患者给药有效量的抗FRα抗体药物偶联物。